Sight for sore eyes

An inventive breakthrough from the Applied Optics Group at the University of Kent at Canterbury (UKC) is set to revolutionise current methods of eye examinations.

Professor David Jackson, Dr Adrian Podoleanu and Dr John Rogers, who gained his doctorate at Kent, have developed an instrument known as an Optical Dual Channel Tomograph. The instrument blends together two imaging technologies. Although in its early stages, it is already being used by ophthalmologists and researchers at New York`s famous Eye and Ear Infirmary and the Retina Research Macula Foundation in New York.

Dr Adrian Podoleanu, of the Applied Optics Group in the School of Physical Sciences, explains that `merging these two technologies offers doctors an in-depth view of eye tissue and patients a less invasive, more comfortable diagnosis`. Dr Podoleanu himself has undergone eye tests using older technologies, for research purposes, and recalls that they may have after-effects – loss of colour vision etc – that can last for hours. The new instrument was built with funding from Ophthalmic Technologies Inc (OTI) Toronto, Canada.

It is hoped that the system, which started out as a bench version filling a laboratory and now exists as a compact chin-rest assembly, will bring more comfortable and more accurate diagnostics to doctors and patients round the world.

Media Contact

Posie Bogan alphagalileo

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Lower dose of mpox vaccine is safe

… and generates six-week antibody response equivalent to standard regimen. Study highlights need for defined markers of mpox immunity to inform public health use. A dose-sparing intradermal mpox vaccination regimen…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

Partners & Sponsors